Corporate Board Profile
Tech Score: 100/100
2 mention(s) identify VISHWAS SESHADRI, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. | 2023-04-13 | Vishwas Seshadri, 47, was appointed our President, Chief Executive Officer and a director on October 15, 2021. | Ph.D. in Microbiology, Immunology & Molecular Biology; has experience in research and development, including roles that likely involved technical skills. |
| ABEONA THERAPEUTICS INC. | 2024-03-19 | Vishwas Seshadri, 48, was appointed our President, Chief Executive Officer and a director on October 15, 2021. | Has a Ph.D. in Microbiology, Immunology & Molecular Biology and experience in research and development, including roles that likely involved technical skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-13 | Vishwas Seshadri, 47, was appointed our President, Chief Executive Officer and a director on October 15, 2021. |
| 2024-03-19 | Vishwas Seshadri, 48, was appointed our President, Chief Executive Officer and a director on October 15, 2021. |
Data sourced from SEC filings. Last updated: 2025-07-01